Immucell (ICCC) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Immucell Corporation  (NASDAQ: ICCC)

Select the Financial Report: Select the Period:


Description of Immucell's Business Segments


ImmuCell Corporation is a biotechnology company that primarily focuses on the development and commercialization of products to enhance animal health and productivity. The company specializes in the fields of livestock, particularly in ruminants such as dairy cows and beef cattle, as well as other companion animals. Below is an extensive description of the key segments, products, and services provided by ImmuCell.

Key Segments

1. Livestock Health Solutions:
ImmuCells primary segment revolves around developing products that improve the health and productivity of livestock. This includes products designed to prevent disease and promote overall well-being in dairy and beef cattle.

2. Companion Animals:
Although the primary focus is on livestock, ImmuCell also targets the companion animal market with specific health solutions to enhance care for pets.

Products

1. Colostrum Supplements:
- First Defense®: This is one of ImmuCells flagship products aimed at newborn calves. It is designed to provide passive immunity by delivering critical antibodies (immunoglobulins) to calves during the first few hours after birth when they are most vulnerable to diseases. Ensuring calves receive adequate colostrum is crucial, as it impacts their health and growth in the early stages of life.

2. Mastitis Prevention:
- Mastitis Treatment Solutions: ImmuCell offers solutions targeting the prevention and management of mastitis in dairy cattle, a common and costly health issue. These products may include both pharmaceuticals and management solutions that help maintain udder health.

3. Probiotics:
- Probiotic formulations may be part of ImmuCell’s portfolio designed to support gut health in livestock. These products can help in improving digestion and nutrient absorption, which is vital for growth and productivity.

4. Vaccines:
- ImmuCell is engaged in the development of vaccines intended to target infectious diseases that affect livestock. These vaccines are designed to stimulate an immune response, providing long-lasting protection against specific pathogens.

5. Diagnostic Products:
- The company may be involved in diagnostic solutions for monitoring the health status of animals, helping producers make informed management decisions. These products facilitate the early detection of health issues that could affect productivity.

Services

1. Consultation and Support:
- ImmuCell provides consultation services to farmers and animal health professionals to educate them about best practices in animal care, specifically around the use of their products. This support helps to ensure the effective implementation of their health solutions.

2. Research and Development:
- The company invests in ongoing research and development to innovate and enhance existing products, as well as to explore new therapeutic and preventive solutions for animal health. This segment includes collaboration with academic institutions and research organizations.

3. Training Programs:
- ImmuCell may offer training programs for farmers and veterinarians to familiarize them with the proper use of their products, the importance of animal health management, and techniques for maximizing productivity through proactive health care practices.

4. Regulatory Support:
- Assistance with understanding and navigating the regulatory requirements involved in animal health products, ensuring that all products meet the necessary safety and efficacy standards.

Market Position

ImmuCell positions itself as a key player in the animal health market, focusing on innovative solutions that address critical health issues in livestock. Their approach emphasizes prevention, particularly in the early stages of an animal’s life, which is essential for the long-term success of livestock operations. The companys commitment to research and consistent improvement of its products aims to enhance farmer productivity and animal welfare.

In summary, ImmuCell Corporation offers a comprehensive range of products and services aimed at enhancing the health and productivity of livestock and companion animals. With a focus on innovative solutions, the company plays a significant role in the growing field of animal biotechnology and health management.


Composition of Immucell Corporation Revenues by Segments

 
US    222.1 % of total Revenue
Non Us    22.03 % of total Revenue
Corporate Segment Scours    242.4 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
US 15.96 222.1 %
Non Us 1.58 22.03 %
Corporate Segment Scours 17.42 242.4 %
Total 7.19 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
US - -
Non Us - -
Corporate Segment Scours - -
Total - -25.59 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Corporate Segment Scours 4.49 25.75 %
Corporate Mastitis -2.49 -
Total 1.84 25.54 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Corporate Segment Scours - -
Corporate Mastitis - -
Total - -5.49 %




Annual Report on Immucell Corporation Divisions, Sales by Country

 
Corporate Mastitis   Corporate Mastitis Segment contribution to total sales 0.72 % of total Revenue
Corporate Scours   Corporate Scours Segment contribution to total sales 100.01 % of total Revenue


Twelve months ended 2025
ICCC s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Corporate Mastitis 0.20 0.72 %
Total 27.45 100 %
Corporate Scours 27.45 100.01 %


Twelve months ended 2025
ICCC s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -1.04 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Corporate Mastitis 9.76 % -
Corporate Scours 4.31 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.